BioDlink International Company Limited (1875.HK) HKSE

3.72

+0.12(+3.33%)

Updated at June 02 04:08PM

Currency In HKD

BioDlink International Company Limited

Address

No. 120 Changyang Street

Suzhou, 215024

China

Phone

86 512 6296 5186

Sector

Healthcare

Industry

Biotechnology

Employees

611

First IPO Date

November 08, 2019

Key Executives

NameTitlePayYear Born
Jincai LiExecutive Director01973
Li YinChief Technology Officer01966
Jian Bo ZhangChief Operating Officer01978
Shan FuExecutive Chairperson of the Board01969
Wing Yat LuiJoint Company Secretary01990
Yifan ChenJoint Company Secretary01980
Ben XiaoGroup Vice President of Finance & Investor Relations01982

Description

BioDlink International Co., Ltd. is clinical stage biopharmaceutical company, which engages in developing and commercializing oncology drugs and therapies. Its product portfolio includes: TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009 and is headquartered in Suzhou, China.